No Benefit Seen From HSCT in Hypodiploid B-ALL

Clinical outcomes of patients with hypodiploid B-ALL are poor compared with those with B-ALL not characterized by hypodiploidy, according to researchers.

from Latest articles from Cancer Therapy Advisor Hematologic Cancers https://ift.tt/2GxLm0R